| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 143.54B | 139.87B | 122.67B | 113.05B | 103.74B | 104.12B |
| Gross Profit | 40.60B | 39.59B | 27.14B | 24.09B | 23.20B | 22.36B |
| EBITDA | 12.77B | 11.41B | 9.64B | 9.58B | 9.17B | 9.14B |
| Net Income | 7.34B | 5.83B | 5.68B | 5.66B | 6.18B | 5.15B |
Balance Sheet | ||||||
| Total Assets | 96.57B | 100.80B | 92.64B | 87.89B | 82.14B | 81.28B |
| Cash, Cash Equivalents and Short-Term Investments | 32.05B | 33.54B | 31.39B | 32.45B | 32.86B | 33.16B |
| Total Debt | 6.14B | 6.11B | 1.75B | 1.90B | 2.97B | 3.76B |
| Total Liabilities | 26.27B | 30.76B | 23.49B | 22.41B | 20.49B | 24.59B |
| Stockholders Equity | 66.97B | 66.69B | 68.13B | 64.34B | 60.37B | 55.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -243.00M | 5.02B | 7.01B | 3.47B | 6.87B |
| Operating Cash Flow | 0.00 | 1.70B | 5.47B | 7.76B | 4.46B | 7.48B |
| Investing Cash Flow | 0.00 | 1.80B | -2.92B | -4.68B | -1.84B | -17.00M |
| Financing Cash Flow | 0.00 | -2.04B | -3.34B | -3.55B | -3.07B | -3.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥127.84B | 20.19 | 15.81% | 2.93% | 84.20% | 137.87% | |
71 Outperform | ¥90.51B | 14.58 | ― | 2.19% | 4.72% | 47.55% | |
67 Neutral | ¥47.01B | 13.35 | ― | 2.93% | 26.99% | -26.97% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥75.71B | 23.41 | 1.46% | 1.18% | 6.40% | 230.12% | |
62 Neutral | ¥70.10B | 8.53 | ― | 2.89% | -3.09% | -35.66% | |
61 Neutral | ¥107.55B | 13.40 | ― | 1.93% | 11.54% | 50.62% |